companies / silkbiomaterials-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 2,700,0002.7M | ○ |
|---|---|---|
| founded | null | |
| hq | Milan, Italy | |
| industry | unknown | |
| stage | null |
KLISBio develops regenerative-medicine implants using silk fibroin as a biocompatible scaffold for orthopedic and vascular use. It serves surgeons performing repairs such as rotator cuff, spinal fusion and nerve repair. Its silk fibroin scaffolds promote tissue regeneration without cells or genetic material.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-04-01 | grant | 2,700,0002.7M | null | ○ |
Google Analytics, Google Tag Manager, DoubleClick Floodlight, Cookiebot, WordPress, BySide, Ruby, Python, PHP, MySQL
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |